Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
379571
Reference Type
Journal Article
Title
Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze
Author(s)
Calixto, AV; Duarte, FS; Duzzioni, M; Nascimento Hackl, LP; Faria, MS; De Lima, TC
Year
2010
Is Peer Reviewed?
Yes
Journal
Behavioural Brain Research
ISSN:
0166-4328
EISSN:
1872-7549
Volume
207
Issue
1
Page Numbers
112-117
Language
English
PMID
19800925
DOI
10.1016/j.bbr.2009.09.037
Web of Science Id
WOS:000273857200015
Abstract
The L-arginine/nitric oxide (NO)/cGMP pathways have been implicated in the control of a variety of physiological mechanisms and are believed to participate in the modulation of anxiety in the CNS. The aim of this study was to investigate the effects of N(G)-nitro-L-arginine-methyl-ester (L-NAME), a non-selective inhibitor of NO synthase (NOS); 7-nitroindazole (7-NI), a preferential inhibitor of neuronal NOS; and sodium nitroprusside (SNP), an NO donor, administered into the ventral hippocampus (VH) of rats submitted to the elevated T-maze (ETM). The ETM, an animal model derived from the elevated plus-maze, allows the measurement of two defensive behavioral responses in the same rat: inhibitory avoidance and escape. Results showed that L-NAME and 7-NI impaired the acquisition of inhibitory avoidance and prolonged escape latency in the ETM, suggesting an anxiolytic-like and panicolytic-like effect, respectively. SNP facilitated the acquisition of inhibitory avoidance without interfering with escape performance, suggesting an anxiogenic-like effect. Treatment with methylene blue did not alter per se any of the behavioral responses measured in the ETM, but blocked the effect promoted by SNP. Thus, altogether these results suggest that NO in the VH is critically involved in the modulation of defensive behavior of rats exposed to the ETM.
Keywords
0 (Anti-Anxiety Agents)0 (Enzyme Inhibitors)0 (Indazoles)0 (Nitric Oxide Donors)10102-43-9 (Nitric Oxide)15078-28-1 (Nitroprusside)2942-42-9 (7-nitroindazole)50903-99-6 (NG-Nitroarginine Methyl Ester)61-73-4 (Methylene Blue)7665-99-8 (Cyclic GMP)EC 1.14.13.39 (Nitric Oxide Synthase)Analysis of VarianceAnimalsAnti-Anxiety Agents/pharmacologyAnxiety/*metabolismAvoidance Learning/drug effects/physiologyBehavior, Animal/physiologyCyclic GMP/*metabolismDose-Response Relationship, DrugEnzyme Inhibitors/pharmacologyEscape Reaction/drug effects/*physiologyExploratory Behavior/drug effectsHippocampus/drug effects/*metabolismIndazoles/pharmacologyMaleMethylene Blue/pharmacologyMotor Activity/drug effectsNG-Nitroarginine Methyl Ester/pharmacologyNitric Oxide/*metabolismNitric Oxide Donors/pharmacologyNitric Oxide Synthase/metabolismNitroprusside/pharmacologyRatsRats, WistarStaining and Labeling
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity